Phapros Tbk PT Cash Flow Conversion Efficiency

Latest as of June 2026: 0.094x

Phapros Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Phapros Tbk PT (PEHA) has a cash flow conversion efficiency ratio of 0.094x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp41.13 Billion ≈ $2.41 Million USD) by net assets (Rp438.24 Billion ≈ $25.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Phapros Tbk PT (2011–2025)

Cash flow conversion efficiency of Phapros Tbk PT from 2011 to 2025. This chart illustrates how Phapros Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PEHA stock price for real-time trading data and today's change.

Phapros Tbk PT Cash Flow Conversion Ratio Explained

Phapros Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Phapros Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phapros Tbk PT ranked by their cash flow conversion efficiency. Also see Phapros Tbk PT stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mico BioMed Co. Ltd. KQ:214610	-0.315x
Daesang Corp Preference Shares KO:001685	0.058x
Imexhs Ltd AU:IME	-0.103x
Nafpaktos Textile Industry S.A AT:NAYP	0.024x
Destinasi Tirta Nusantara Tbk JK:PDES	0.250x
Wintao Communications Co. Ltd SHE:301139	0.002x
Bass Oil Ltd AU:BAS	-0.041x
Bd Multimedia PA:ALBDM	0.061x

Annual Cash Flow Conversion Efficiency for Phapros Tbk PT (2011–2025)

The table below shows the annual cash flow conversion efficiency of Phapros Tbk PT from 2011 to 2025. Review Phapros Tbk PT (PEHA) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Rp427.47 Billion ≈ $25.05 Million	Rp70.98 Billion ≈ $4.16 Million	0.166x	-53.79%
2024-12-31	Rp393.12 Billion ≈ $23.04 Million	Rp141.28 Billion ≈ $8.28 Million	0.359x	+2016.64%
2023-12-31	Rp770.33 Billion ≈ $45.14 Million	Rp-14.44 Billion ≈ $-846.35K	-0.019x	-151.56%
2022-12-31	Rp771.82 Billion ≈ $45.23 Million	Rp28.07 Billion ≈ $1.64 Million	0.036x	-85.81%
2021-12-31	Rp740.98 Billion ≈ $43.42 Million	Rp189.92 Billion ≈ $11.13 Million	0.256x	-26.81%
2020-12-31	Rp740.91 Billion ≈ $43.41 Million	Rp259.48 Billion ≈ $15.20 Million	0.350x	+11694.31%
2019-12-31	Rp821.61 Billion ≈ $48.14 Million	Rp-2.48 Billion ≈ $-145.42K	-0.003x	+96.86%
2018-12-31	Rp789.80 Billion ≈ $46.28 Million	Rp-75.91 Billion ≈ $-4.45 Million	-0.096x	-166.07%
2017-12-31	Rp701.39 Billion ≈ $41.10 Million	Rp102.03 Billion ≈ $5.98 Million	0.145x	-20.68%
2016-12-31	Rp622.08 Billion ≈ $36.45 Million	Rp114.08 Billion ≈ $6.68 Million	0.183x	+17.67%
2015-12-31	Rp449.72 Billion ≈ $26.35 Million	Rp70.09 Billion ≈ $4.11 Million	0.156x	-24.29%
2014-12-31	Rp408.25 Billion ≈ $23.92 Million	Rp84.04 Billion ≈ $4.92 Million	0.206x	+313.18%
2013-12-31	Rp391.40 Billion ≈ $22.93 Million	Rp19.50 Billion ≈ $1.14 Million	0.050x	-67.11%
2012-12-31	Rp375.63 Billion ≈ $22.01 Million	Rp56.90 Billion ≈ $3.33 Million	0.151x	+288.78%
2011-12-31	Rp339.17 Billion ≈ $19.87 Million	Rp-27.22 Billion ≈ $-1.59 Million	-0.080x	--

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$12.99 Million

Rp221.76 Billion IDR

Market Cap Rank

#26234 Global

#567 in Indonesia

Share Price

Rp264.00

Change (1 day)

+0.00%

52-Week Range

Rp214.00 - Rp384.00

All Time High

Rp2996.89